Geriatric Nutritional Risk Index As an Independent Prognostic Factor in Locally Advanced Nasopharyngeal Carcinoma Treated Using Radical Concurrent Chemoradiotherapy: a Retrospective Cohort Study.
Qing-Nan Tang,Hui-Zhi Qiu,Xiao-Qing Sun,Shan-Shan Guo,Li-Ting Liu,Yue-Feng Wen,Sai-Lan Liu,Hao-Jun Xie,Yu-Jing Liang,Xue-Song Sun,Xiao-Yun Li,Jin-Jie Yan,Jin-Hao Yang,Dong-Xiang Wen,Ling Guo,Lin-Quan Tang,Qiu-Yan Chen,Hai-Qiang Mai
DOI: https://doi.org/10.21037/atm-20-6493
IF: 3.616
2021-01-01
Annals of Translational Medicine
Abstract:Background: Nutritional status is a key factor influencing the prognosis of patients with cancer. The Geriatric Nutritional Risk Index (GNRI) has been used to predict mortality risk and long-term outcomes. In this study, we aimed to evaluate the predictive value of pretreatment GNRI in patients with nasopharyngeal carcinoma (NPC). Methods: A total of 1,065 patients with biopsy-proven non-disseminated nasopharyngeal carcinoma were included. Based on a cutoff value of pretreatment GNRI, patients were divided into two groups (low =107.7 and high >107.7). Combining GNRI and baseline Epstein-Barr virus (EBV) DNA, all patients were further stratified into three risk groups, namely, high-risk (high EBV DNA and low GNRI), low-risk (low EBV DNA and high GNRI), and medium-risk (except the above) groups. Multivariate analyses were performed using the Cox proportional hazards model to assess the predictive value of the GNRI. Results: Among the 1,065 patients, 527 (49.5%) and 538 (50.5%) were divided into low and high GNRI groups, respectively. Within a median follow-up of 83 months, patients with a high GNRI score exhibited significantly higher overall survival (OS), progression-free survival (PFS), and distant metastasis-free survival (DMFS) compared to those with low GNRI scores (P<0.05). Multivariate analyses revealed that high GNRI is an independent prognostic factor for OS and PFS (hazard ratio, HR, 0.471, 95% CI, 0.270-0.822, P=0.008; HR 0.638, 95% CI, 0.433-0.941, P=0.023, respectively). Using a combination of baseline GNRI and EBV DNA, a satisfying separation of survival curves between different risk groups for OS, PFS, DMFS was observed. The survival rates of patients in the high-risk group were significantly lower than those in the low- and medium- risk groups (all P<0.001). The combined classification was demonstrated to be an independent prognostic factor for OS and PFS after adjustment using multivariate analysis. Conclusions: Pretreatment GNRI is an independent prognostic factor for NPC patients. The combination of baseline GNRI score and EBV DNA level improved the prognostic stratification of NPC patients.